Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy with bleomycin for palliative treatment of head and neck squamous cell carcinoma
2013-002647-29Phase 2Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bleomycin in head and neck squamous cell carcinoma (HNSCC), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Change in Edmonton quality of life test score at 6 weeks. Started Dec 2013; status: active.
02
Drugs
bleomycin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2013-002647-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002647-29.